Yet another paper which emphasises the importance of thyroid hormone for the heart. But still emphasises levothyroxine alone (in the abstract, at least).
Heart Fail Clin. 2019 Jul;15(3):393-398. doi: 10.1016/j.hfc.2019.02.008. Epub 2019 Apr 5.
The Management of Thyroid Abnormalities in Chronic Heart Failure.
Biondi B1.
Author information
Abstract
The cardiovascular system is one of the main targets of thyroid hormone action, and triiodothyronine deficiency has crucial consequences on cardiac structure and function. Patients with overt or subclinical hypothyroidism should be treated with levothyroxine to improve their cardiovascular function and the potential risk of heart failure. Even patients with thyroid hormone deficiency and heart failure should receive replacement doses of levothyroxine to improve their prognosis and worsening of the cardiovascular function. An innovative therapeutic multifactorial approach could improve the progression of heart failure. There is a potential beneficial effect of thyroid hormones and their analogs in patients with heart failure.
Copyright © 2019 Elsevier Inc. All rights reserved.
KEYWORDS:
Cardiac fetal phenotype; Heart failure; Hypothyroidism; Levothyroxine; Low T3 syndrome; liothyronine
PMID: 31079697
DOI: 10.1016/j.hfc.2019.02.008
ncbi.nlm.nih.gov/pubmed/310...
The first page is available to read - adds a little to the abstract: